Science Daily

Machine learning classifier accelerates the development of cellular immunotherapies

Making a personalized T cell therapy for cancer patients currently takes at least six months. Scientists have shown that the laborious first step of identifying tumor-reactive T cell receptors for ...
News Medical

Machine learning classifier reduces the time to identify personalized tumor reactive T cell receptors

Making a personalized T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have ...
ascopubs.org

Machine learning–derived B-cell epitopes classifiers for early detection of renal cell carcinoma.

Real-world quality of life (QOL) in patients (pts) with metastatic renal cell carcinoma (mRCC) on active surveillance (AS) in the ODYSSEY prospective observational study. This is an ASCO Meeting ...
ascopubs.org

Delta-Radiomics Using Machine Learning Classifiers With Auxiliary Data Sets to Predict Disease Progression During Magnetic Resonance-Guided Radiotherapy in Adrenal Metastases

Decision trees provided an explainable model on the external data set. The validation of our model on an external data set may be the first step to biologically adapted radiotherapy recognizing ...
Seeking Alpha

MicroAlgo Inc. Develops Classifier Auto-Optimization Technology Based on Variational Quantum Algorithms, Accelerating the Advancement of Quantum Machine Learning

SHENZHEN, China, May 2, 2025 /PRNewswire/ -- MicroAlgo Inc. (MLGO) (the "Company" or "MicroAlgo") announced today the launch of their latest classifier auto-optimization technology based on ...
Healio

Explainable machine learning can improve efforts to diagnose CKD early

Please provide your email address to receive an email when new articles are posted on . Explainable machine learning can offer accurate diagnoses and identify causes of chronic kidney disease in early ...
EurekAlert!

Machine learning classifier accelerates the development of cellular immunotherapies

Making a personalised T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have ...